Intravenous magnesium does not influence the activity of the coagulation cascade

Blood Coagulation and Fibrinolysis

Volumn 12, Issue 4, 2001, Pages 223-228

  Ravn, Hanne B ^a   Lassen, J F ^a   Bergenhem, N ^b   Kristensen, A T ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b NOVO NORDISK A S   (Denmark)

Author keywords

Coagulation cascade; Coagulation markers; Healthy volunteers; Magnesium

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 8A; CITRIC ACID; FIBRIN DEGRADATION PRODUCT; MAGNESIUM SULFATE; PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX;

ADULT; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; FIBRINOLYSIS; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE; THROMBOGENESIS; VOLUNTEER;

ADULT; BLOOD COAGULATION; HUMANS; INFUSIONS, INTRAVENOUS; MAGNESIUM; MALE;

EID: 0034968590     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200106000-00001     Document Type: Article

References (32)

1. Intravenous magnesium sulphate in suspected myocardial infarction: Results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)
2. ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected myocardial infarction
3. Magnesium sulphate reduces myocardial infarct size when administered before but not after coronary reperfusion in a canine model
4. Timing of magnesium therapy affects experimental infarct size
5. Early administration of intravenous magnesium inhibits arterial thrombus formation
6. Possible pharmacological actions of magnesium in acute myocardial infarction
7. Interventions for acute ischemia: Magnesium
8. Magnesium in acute MI timing is critical
9. Intravenous magnesium reduces infarct size after ischemia/reperfusion injury combined with a thrombogenic lesion in the LAD
10. The effects of agents which modify platelet behavior and of magnesium ions on thrombus formation in vivo
11. Effect of magnesium sulphate on thrombus formation following partial arterial constriction: Implications for coronary vasospasms
12. Platelet activation mechanisms and markers in arterial thrombosis
13. Effect of extracellular magnesium on platelet activation and intracellular Ca mobilization
14. Effect of magnesium on platelet aggregation and adhesion
15. Magnesium inhibits platelet activity - An in vitro study
16. Magnesium inhibits platelet activity: An infusion study in healthy volunteers
17. Magnesium: Nature's physiologic calcium blocker
18. Prothrombin fragments F1 + 2, thrombin-antithrombin III complexes, fibrin monomers and fibrinogen in patients with coronary atherosclerosis
19. Effect of magnesium on coagulation as measured by thromboelastography
20. The effect of ionised magnesium on coagulation using thromboelastography
21. Thromboelastography in healthy laboring women and in women receiving magnesium for premature labor
22. Hemostatic changes after early versus late intracoronary magnesium during acute myocardial infarction in swine
23. Intracoronary magnesium and diltiazem affect to a similar extent certain hemostatic factors during acute myocardial infarction in swine
24. Chronic coronary heart disease
25. Magnesium therapy, fibrinolytic parameters and von Willebrand factor in acute myocardial in farction
26. Bolus magnesium infusion in humans is associated with predominantly unfavorable changes in platelet aggregation and certain hemaostatic factors
27. Overview of the coagulation reactions
28. Blood coagulation
29. Differentiation of metal ion-induced transistions of prothrombin fragment 1
30. 2+ binding to the first epidermal growth factor-like domain of human blood coagulation Factor IX promotes enzyme activity and Factor VIII light chain binding
31. Regulation of the tertiary structure and function of coagulation Factor IX by magnesium (II) ions
32. Magnesium (II) is crucial constituent of the blood coagulation cascade